Supercharged immune cells join the fight against tough cancers
NCT ID NCT04847466
Summary
This study is testing a new combination of three immune-based treatments for adults with advanced stomach or head and neck cancer that has returned or spread after standard therapy. The treatment involves giving patients specially engineered immune cells (CAR-NK cells) along with two other drugs designed to help the immune system attack cancer. The main goal is to see if this combination can shrink tumors and keep the cancer from getting worse for at least six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.